http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1306378-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d6256baf554e46784d8daa478a2ddc6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00 |
filingDate | 2001-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e779195b2e9ca08d695df1fcdc3602d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689399350a8ee9de0e08782d3a5146aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774bd99a897426751804e48bf5dbd105 |
publicationDate | 2003-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1306378-A1 |
titleOfInvention | Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
abstract | Medicines for treatment or prevention of dementiancomprising 2-aryl-8-oxodihydropurine derivatives of thenformula (I):n nwherein W is H, C 1-6 alkyl, halogen, C 1-6 alkoxy, or thenlike; X is H, C 1-6 alkyl, a group of the formula (Q):-CH(R 3 )CON(R 1 )(R 2 )(whereinnR 1 is a C 1-6 alkyl or the like; R 2 nis phenyl-substituted C 1-4 alkyl or the like; and R 3 is H ornthe like); Y is H, C 1-6 alkyl, a group of the above formulan(Q), or the like; and A is substituted phenyl or the like,nwith the proviso that one of X and Y is a group of thenformula (Q) and the other is a group selected from thosendefined for X or Y except the groups (Q), ornpharmaceutically acceptable acid addition salts thereof.nThe above compounds exhibit an extremely potentnameliorating effect on learning disorder and/or dymnesianand thus are useful in the treatment or prevention ofnAlzheimer-type dementia, cerebrovascular dementia, senilendementia, etc. |
priorityDate | 2000-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 200.